Betahistine hydrochloride - Meniere's disease
You are here : Home > Formulary Search > Betahistine hydrochloride - Meniere's disease
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Betahistine hydrochloride
Indication :
Meniere's disease
Group Name :
Keywords :
Meniere's syndrome, vertigo, hearing loss, tinnitus, vestibular disorders
Brand Names Include :
Serc
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Betahistine hydrochloride is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Meniere's disease.
- No records returned.
Committee Recommendations (1)
The Surrey & North West Sussex Area Prescribing Committee (APC) recommend the prescribing o betahistine for the treatment of Meniere's Disease in line with NICE Clinical Knowledge Summaries (CKS) https://cks.nice.org.uk/menieres-disease
NOTE - the branded product, Serc, was considered BLACK at the PCN in May 2017. https://surreyccg.res-systems.net/PAD/Search/DrugConditionProfile/5580